A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- jin li, MD, PHD
Fudan University
Principal Investigator - shukui qin, MD, PHD
81th Hospital of PLA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
- Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
- Affiliated Hospital of Military Medical Sciences
Beijing, Beijing Municipality, China
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
- Beijing Union Medical College Hospital
Beijing, Beijing Municipality, China
- Chinese Academy of Medical Sciences Cancer Hospital
Beijing, Beijing Municipality, China
- Pla General Hospital (301 Hospital)
Beijing, Beijing Municipality, China
- Fujian Provincial Tumor Hospital
Fuzhou, Fujian, China
- Fuzhou General Hospital of Nanjing Military Region
Fuzhou, Fujian, China
- Cancer Hospital of Harbin Medical University
Harbin, Heilongjiang, China
- Jiangyin City People'S Hospital
Jiangyin, Jiangsu, China
- Jiangsu Province Tumor Hospital
Nanjing, Jiangsu, China
- Second Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China
- First People'S Hospital Cancer Center, Shanghai Jiaotong University
Shanghai, Shanghai Municipality, China
- Shanghai Changhai Hospital
Shanghai, Shanghai Municipality, China
- Shanghai Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China
- Shanghai Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
- Shanghai Jiaotong University Affiliated Ruijin Hospital
Shanghai, Shanghai Municipality, China
- Shanghai Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
- Affiliated Xijing Hospital, Fourth Military Medical University
Xi’an, Shanxi, China
- General Hospital of Chengdu Military Region
Chengdu, Sichuan, China
- First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
- Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
- Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China
- Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2015
- Primary completion
- 30 Nov 2021
- Completion
- 30 Nov 2021
- Last update posted
- 4 Apr 2024
- Registered enrollment
- 90
- Registry id
- NCT02395016
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.